Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study

被引：0
|
作者：
Henok Tadesse Ayele
Maaike SM van Mourik
Marc JM Bonten
机构：
[1] University Medical Center Utrecht,Julius Center for Health Sciences and Primary Care, Infectious Diseases Epidemiology
[2] University Medical Center Utrecht,Department of Medical Microbiology and Infection Control
[3] Dilla University College of Medicine & Health Sciences and Referral Hospital,Department of Public Health
来源：
BMC Infectious Diseases | / 15卷
关键词：
Human Immunodeficiency Virus; Human Immunodeficiency Virus Infection; Tuberculin Skin Test; Human Immunodeficiency Virus Patient; Human Immunodeficiency Virus Disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study
    Ayele, Henok Tadesse
    van Mourik, Maaike Sm
    Bonten, Marc J. M.
    BMC INFECTIOUS DISEASES, 2015, 15
  • [2] Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study
    Amon Sabasaba
    Henry Mwambi
    Geoffrey Somi
    Angella Ramadhani
    Michael J. Mahande
    BMC Infectious Diseases, 19
  • [3] Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study
    Sabasaba, Amon
    Mwambi, Henry
    Somi, Geoffrey
    Ramadhani, Angella
    Mahande, Michael J.
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [4] Effectiveness of a six-month Isoniazid as tuberculosis preventive therapy in people living with HIV in eritrea: A retrospective cohort study
    Russom, Mulugeta
    Stricker, Bruno
    Woldu, Henok G.
    Berhane, Araia
    Jeannetot, Daniel
    Verhamme, Katia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 209 - 210
  • [5] Safety and tolerability of isoniazid preventive therapy for tuberculosis for persons with HIV with and without alcohol use
    Hahn, Judith A.
    Ngabirano, Christine
    Fatch, Robin
    Emenyonu, Nneka I.
    Cheng, Debbie M.
    Adong, Julian
    Tumwegamire, Adah
    Terrault, Norah A.
    Linas, Benjamin P.
    Jacobson, Karen R.
    Muyindike, Winnie R.
    AIDS, 2023, 37 (10) : 1535 - 1543
  • [6] The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study
    Lelisa Fekadu Assebe
    Hailemariam Lemma Reda
    Alem Desta Wubeneh
    Wondwossen Terefe Lerebo
    Saba Maria Lambert
    BMC Public Health, 15
  • [7] The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study
    Assebe, Lelisa Fekadu
    Reda, Hailemariam Lemma
    Wubeneh, Alem Desta
    Lerebo, Wondwossen Terefe
    Lambert, Saba Maria
    BMC PUBLIC HEALTH, 2015, 15
  • [8] Isoniazid preventive therapy and tuberculosis transcriptional signatures in people with HIV
    Valinetz, Ethan D.
    Matemo, Daniel
    Gersh, Jill K.
    Joudeh, Lara L.
    Mendelsohn, Simon C.
    Scriba, Thomas J.
    Hatherill, Mark
    Kinuthia, John
    Wald, Anna
    Cangelosi, Gerard A.
    Barnabas, Ruanne V.
    Hawn, Thomas R.
    Horne, David J.
    AIDS, 2022, 36 (10) : 1363 - 1371
  • [9] ISONIAZID PREVENTIVE TUBERCULOSIS THERAPY
    SNIDER, DE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (21): : 2984 - 2984
  • [10] Mortality benefit of isoniazid preventive therapy in HIV-positive persons: a simulation study
    Bachhuber, M. A.
    Gross, R.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (08) : 1038 - 1040
12345